Functional genomics to reveal novel opportunities for CD20 antibody therapy of B-cell malignancies
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F18%3A00105994" target="_blank" >RIV/00216224:14110/18:00105994 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Functional genomics to reveal novel opportunities for CD20 antibody therapy of B-cell malignancies
Original language description
Functional genomics to reveal novel opportunities for CD20 antibody therapy of B-cell malignancies. Functional genomics to reveal novel opportunities for CD20 antibody therapy of B-cell malignancies. Functional genomics to reveal novel opportunities for CD20 antibody therapy of B-cell malignancies.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů